TMCnet News
Follicular Thyroid Cancer Drug Profiles and Clinical Trials Report - Global Trends and Analysis Review, H2 2017 - Research and MarketsThe "Follicular Thyroid Cancer Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H2 2017" report has been added to Research and Markets' offering. Follicular Thyroid Cancer clinical trials report provides comprehensive analysis and trends in global Follicular Thyroid Cancer disease clinical trials. The research work analyzes the evolution of Follicular Thyroid Cancer clinical trial trends across countries and regions. The report focuses on drugs and therapies being evaluated for Follicular Thyroid Cancer treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types. Major drugs under development in Follicular Thyroid Cancer are provided in the report along with their details of Mechanism of Action, Route of Administration, Target (News - Alert), therapy, molecule and class. Scope of the Report:
Types: Thyroid Cancer is categorized into three main types:
Stages:
Companies conducting Follicular Thyroid Cancer trials include:
For more information about this report visit https://www.researchandmarkets.com/research/6gc64r/follicular View source version on businesswire.com: http://www.businesswire.com/news/home/20171120005997/en/ |